London & Capital Glb Eq Opps X GBP H Acc

Performance History30/09/2024
Growth of 1,000 (EUR)
London & Capital Glb Eq Opps X GBP H Acc
Fund---35.414.0
+/-Cat-----
+/-Idx-----
 
Key Stats
NAV
16/10/2024
 GBP 133.61
Day Change -1.55%
Morningstar Category™ Other Equity
ISIN IE000G94VZU1
Fund Size (Mil)
17/10/2024
 USD 46.06
Share Class Size (Mil)
17/10/2024
 USD 11.16
Max Initial Charge -
Ongoing Charge
01/01/2023
  0.82%
Investment Objective: London & Capital Glb Eq Opps X GBP H Acc
To seek to provide long-term capital growth through investments in global equities.
Returns
Trailing Returns (EUR)16/10/2024
YTD10.51
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
-
-
Inception Date
25/05/2022
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
--
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  London & Capital Glb Eq Opps X GBP H Acc31/07/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.670.0096.67
Bonds0.000.000.00
Cash3.360.033.33
Other0.000.000.00
Top 5 Regions%
United States83.73
Eurozone8.56
Asia - Developed4.48
Europe - ex Euro3.22
Canada0.00
Top 5 Sectors%
Technology31.89
Healthcare26.72
Financial Services20.97
Communication Services8.15
Consumer Cyclical5.87
Top 5 HoldingsSector%
Alphabet Inc Class CCommunication ServicesCommunication Services7.88
Cadence Design Systems IncTechnologyTechnology6.36
Repligen CorpHealthcareHealthcare5.82
Microsoft CorpTechnologyTechnology5.80
Intuitive Surgical IncHealthcareHealthcare5.19
London & Capital Glb Eq Opps X GBP H Acc

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures